Neurologic outcome in children after extracorporeal membrane oxygenation: prognostic value of diagnostic tests

Angela Amigoni1, Andrea Pettenazzo, Paolo Biban

  • 1Department of Paediatrics, University of Padua, Via Giustiniani 3, 35128 Padua, Italy.

Pediatric Neurology
|February 26, 2005
PubMed

Insights

Long-term neurologic outcomes for neonates and children surviving extracorporeal membrane oxygenation (ECMO) show persistent negative results. Electroencephalogram, neuroimaging, and somatosensory evoked potentials predict poor neurologic outcomes in these vulnerable populations.

Area of Science:

  • Pediatric Intensive Care
  • Neurology
  • Neonatal Medicine

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a life-support measure for critically ill neonates and children.
  • Long-term neurodevelopmental outcomes after ECMO are not fully understood.
  • Identifying prognostic indicators is crucial for patient management and counseling.

Purpose of the Study:

  • To evaluate the 36-month neurologic outcome in neonates and children after ECMO.
  • To identify prognostic indicators of neurologic outcome following ECMO treatment.

Main Methods:

  • Prospective study in a pediatric intensive care unit.
  • Involved 12 neonates and 9 children surviving ECMO.
  • Assessed neurologic outcomes using neurodevelopmental tests, evoked potentials (auditory, visual, somatosensory), electroencephalogram, and neuroimaging at multiple time points (6, 12, 24, 36 months).
  • Analyzed pre- and during-ECMO clinical variables.

Main Results:

  • Negative neurologic outcomes were observed in 8.3% of neonates and 30% of children at 12 months post-ECMO, with no significant changes at 24 or 36 months.
  • Abnormal electroencephalogram (especially the first and most abnormal during ECMO), neuroimaging scores, and somatosensory evoked potentials were associated with negative outcomes.
  • Pre-ECMO oxygenation index and pH, and during-ECMO pH, oxygen partial pressure, and bypass duration were also analyzed.

Conclusions:

  • Neonates and children treated with ECMO require long-term neurologic follow-up.
  • Electroencephalogram, neuroimaging, and somatosensory evoked potentials are valuable prognostic indicators for adverse neurologic outcomes after ECMO.
  • Early identification of at-risk patients can guide therapeutic strategies and support.

Related Concept Videos